258 related articles for article (PubMed ID: 26277324)
21. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.
Zaveri NT; Jiang F; Olsen C; Polgar WE; Toll L
Bioorg Med Chem Lett; 2013 Jun; 23(11):3308-13. PubMed ID: 23623415
[TBL] [Abstract][Full Text] [Related]
22. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
Liao YY; Lee CW; Ho IK; Chiou LC
Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
[TBL] [Abstract][Full Text] [Related]
23. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
24. Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.
Machelska H; Celik MÖ
Front Immunol; 2020; 11():300. PubMed ID: 32194554
[TBL] [Abstract][Full Text] [Related]
25. Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin Receptors.
Zhuo GY; Chen MC; Lin TY; Lin ST; Chen DT; Lee CW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674576
[TBL] [Abstract][Full Text] [Related]
26. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
Wtorek K; Janecka A
Chem Biodivers; 2021 Jan; 18(1):e2000871. PubMed ID: 33351271
[TBL] [Abstract][Full Text] [Related]
27. Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.
Schiene K; Schröder W; Linz K; Frosch S; Tzschentke TM; Jansen U; Christoph T
Eur J Pharmacol; 2018 Aug; 832():90-95. PubMed ID: 29753041
[TBL] [Abstract][Full Text] [Related]
28. A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.
Ding H; Kiguchi N; Yasuda D; Daga PR; Polgar WE; Lu JJ; Czoty PW; Kishioka S; Zaveri NT; Ko MC
Sci Transl Med; 2018 Aug; 10(456):. PubMed ID: 30158150
[TBL] [Abstract][Full Text] [Related]
29. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.
Scoto GM; Aricò G; Ronsisvalle S; Parenti C
Peptides; 2007 Jul; 28(7):1441-6. PubMed ID: 17628212
[TBL] [Abstract][Full Text] [Related]
30. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
Ding H; Hayashida K; Suto T; Sukhtankar DD; Kimura M; Mendenhall V; Ko MC
Br J Pharmacol; 2015 Jul; 172(13):3302-12. PubMed ID: 25752320
[TBL] [Abstract][Full Text] [Related]
31. Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonism.
Schiene K; Tzschentke TM; Schröder W; Christoph T
Eur J Pharmacol; 2015 May; 754():61-5. PubMed ID: 25697471
[TBL] [Abstract][Full Text] [Related]
32. Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells.
Caputi FF; Lattanzio F; Carretta D; Mercatelli D; Candeletti S; Romualdi P
J Mol Neurosci; 2013 Oct; 51(2):532-8. PubMed ID: 23715695
[TBL] [Abstract][Full Text] [Related]
33. Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors.
Williams JP; Thompson JP; McDonald J; Barnes TA; Cote T; Rowbotham DJ; Lambert DG
Anesth Analg; 2007 Oct; 105(4):998-1005, table of contents. PubMed ID: 17898379
[TBL] [Abstract][Full Text] [Related]
34. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Zaveri NT
Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
[TBL] [Abstract][Full Text] [Related]
35. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
Donica CL; Awwad HO; Thakker DR; Standifer KM
Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
Bird MF; Cerlesi MC; Brown M; Malfacini D; Vezzi V; Molinari P; Micheli L; Di Cesare Mannelli L; Ghelardini C; Guerrini R; Calò G; Lambert DG
PLoS One; 2016; 11(6):e0156897. PubMed ID: 27272042
[TBL] [Abstract][Full Text] [Related]
37. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.
Rekik K; Faria Da Silva R; Colom M; Pacifico S; Zaveri NT; Calo' G; Rampon C; Frances B; Mouledous L
Neuropharmacology; 2017 Oct; 125():39-49. PubMed ID: 28705439
[TBL] [Abstract][Full Text] [Related]
38. Nociceptin/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons.
Anand P; Yiangou Y; Anand U; Mukerji G; Sinisi M; Fox M; McQuillan A; Quick T; Korchev YE; Hein P
Pain; 2016 Sep; 157(9):1960-1969. PubMed ID: 27127846
[TBL] [Abstract][Full Text] [Related]
39. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice.
Ozawa A; Brunori G; Cippitelli A; Toll N; Schoch J; Kieffer BL; Toll L
Br J Pharmacol; 2018 Jul; 175(13):2662-2675. PubMed ID: 29582417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
